Spondyloarthropathy and Gastroesophageal reflux disease

Summary:

Gastroesophageal reflux disease is reported only by a few people with Spondyloarthropathy.

The study analyzes which people have Gastroesophageal reflux disease with Spondyloarthropathy. It is created by eHealthMe based on 4 people who have Gastroesophageal reflux disease and Spondyloarthropathy from the Food and Drug Administration (FDA), and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

4 people who have Spondyloarthropathy and Gastroesophageal Reflux Disease are studied.


What is Spondyloarthropathy?

Spondyloarthropathy (any joint disease of the vertebral column) is found to be associated with 287 drugs and 138 conditions by eHealthMe.

What is Gastroesophageal reflux disease?

Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 3,406 drugs and 2,923 conditions by eHealthMe.

Number of Gastroesophageal reflux disease in Spondyloarthropathy reports submitted per year:

Would you have Gastroesophageal reflux disease when you have Spondyloarthropathy?

Gender of people who have Spondyloarthropathy and experienced Gastroesophageal Reflux Disease *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Spondyloarthropathy and experienced Gastroesophageal Reflux Disease *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 50.00%

Common drugs taken by these people *:

  1. Remicade: 2 people, 50.00%
  2. Plaquenil: 1 person, 25.00%
  3. Humira: 1 person, 25.00%
  4. Gralise: 1 person, 25.00%
  5. Enbrel: 1 person, 25.00%

Common symptoms for these people *:

  1. Pain: 3 people, 75.00%
  2. Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 50.00%
  3. Inflammation: 2 people, 50.00%
  4. Blood Glucose Increased: 2 people, 50.00%
  5. Cyst (a closed sac): 2 people, 50.00%
  6. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 2 people, 50.00%
  7. Infection: 2 people, 50.00%
  8. Irritable Bowel Syndrome: 2 people, 50.00%
  9. Mobility Decreased (ability to move is reduced): 2 people, 50.00%
  10. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastroesophageal reflux disease?

Check whether Gastroesophageal reflux disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastroesophageal reflux disease:

Common drugs associated with Gastroesophageal reflux disease:

All the drugs that are associated with Gastroesophageal reflux disease:

Common conditions associated with Gastroesophageal reflux disease:

All the conditions that are associated with Gastroesophageal reflux disease:

How the study uses the data?

The study is based on Gastroesophageal reflux disease and Spondyloarthropathy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: